Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Pater

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|November 1, 1992
Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials GroupG P Browman, A Belch, J Skillings, et al.
Cancer Treatment Reports|September 1, 1984
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada studyJ A Maroun, A L Fields, J L Pater, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 1997
Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials GroupJ Dancey, B Zee, D Osoba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycleJ L Pater, G P Browman, M C Brouwers, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
A proposal for a new approach to intergroup cancer trialsJ L Pater, B Zee, J Myles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancerB Moy, D Tu, J L Pater, et al.
Current Oncology (Toronto, Ont.)|March 18, 2016
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in CanadaP A Tang, A E Hay, C J O'Callaghan, et al.
Gynecologic Oncology|December 1, 1991
Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical stagingM Monga, J A Carmichael, W E Shelley, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1988
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized TrialP Coy, I Hodson, D G Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lungR Feld, W K Evans, P Coy, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|November 1, 1992
Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials GroupG P Browman, A Belch, J Skillings, et al.
Cancer Treatment Reports|September 1, 1984
Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada studyJ A Maroun, A L Fields, J L Pater, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 1997
Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials GroupJ Dancey, B Zee, D Osoba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycleJ L Pater, G P Browman, M C Brouwers, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
A proposal for a new approach to intergroup cancer trialsJ L Pater, B Zee, J Myles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancerB Moy, D Tu, J L Pater, et al.
Current Oncology (Toronto, Ont.)|March 18, 2016
Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in CanadaP A Tang, A E Hay, C J O'Callaghan, et al.
Gynecologic Oncology|December 1, 1991
Surgery without adjuvant chemotherapy for early epithelial ovarian carcinoma after comprehensive surgical stagingM Monga, J A Carmichael, W E Shelley, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1988
The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized TrialP Coy, I Hodson, D G Payne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lungR Feld, W K Evans, P Coy, et al.
Pageof 7